VETROPOLYCIN Pommade

Country: Канада

Језик: Француски

Извор: Health Canada

Активни састојак:

Bacitracine de zinc; Sulfate de polymyxine b; Néomycine (Sulfate de néomycine)

Доступно од:

DECHRA LTD

Дозирање:

400Unité; 10000Unité; 3.5MG

Фармацеутски облик:

Pommade

Састав:

Bacitracine de zinc 400Unité; Sulfate de polymyxine b 10000Unité; Néomycine (Sulfate de néomycine) 3.5MG

Пут администрације:

Ophtalmique

Јединице у пакету:

3.5G

Тип рецептора:

Prescription

Терапеутска група:

Chats; Chiens

Резиме производа:

Numéro de groupe d'ingrédients actifs (GIA) :0331380003

Статус ауторизације:

APPROUVÉ

Датум одобрења:

2014-09-05

Информативни летак

Dechra March 22, 2023
INNER LABEL – TUBE (3.5 g)
Sterile / Stérile
DIN 02431262
VETROPOLYCIN
Neomycin and Polymyxin B Sulfates and Bacitracin Zinc Ophthalmic
Ointment, Mfr. Std.
Onguent ophtalmique de sulfates de néomycine et de polymyxine B,
et de bacitracine de zinc, Norme du fab.
Veterinary Use Only / Usage vétérinaire seulement
Antibiotic / Antibiotique
3.5 g
DECHRA LTD.
Dechra logo
Cat and Dog picto
CRIMP:
Lot:
Exp.:
Dechra March 22, 2023
INSERT - ENGLISH
DIN 02431262
VETROPOLYCIN
Neomycin and Polymyxin B Sulfates and Bacitracin Zinc
ophthalmic ointment, Mfr. Std.
Veterinary Use Only
Sterile
ACTIVE INGREDIENTS
Each g contains: bacitracin zinc 400 IU, neomycin sulfate 5 mg
(equivalent to 3.5 mg neomycin base)
and polymyxin B sulfate 10,000 IU.
ACTIONS
The three antibiotics present in Vetropolycin
provide a broad spectrum of activity against the gram-
positive and gram-negative bacteria commonly involved in superficial
infections of the eyelid and
conjunctiva. Bacitracin is effective against gram-positive bacteria
including hemolytic and non-hemolytic
streptococci and staphylococci. Resistant strains are rarely found.
Neomycin is effective against both
gram-positive and gram-negative bacteria including staphylococci,
_Escherichia coli_, _Haemophilus _
_influenza_ and many strains of _Proteus_ and _Pseudomonas_. Polymyxin
B is bactericidal to gram-negative
bacteria especially _Pseudomonas_. No resistant strains have been
found to develop _in vivo_.
INDICATIONS
For use in the treatment of superficial bacterial infections of the
eyelid and conjunctiva in dogs and cats
when caused by organisms susceptible to the antibiotics contained in
this ointment. Laboratory tests
should be conducted including _in vitro_ culturing and susceptibility
tests on samples collected prior to
treatment.
DOSAGE AND ADMINISTRATION
Care should be taken not to contaminate the applicator tip of the tube
during administration. Do not allow
the applicator tip to come into contact with any tissue.
Apply a thin film over the cornea three